Institutional investors purchased a net $625.9 thousand shares of ENZ during the quarter ended October 2013. This may signal that the smart money is gaining interest in this company as the 32.43% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PLATTE RIVER CAPITAL LLC Bought 531.0 Thousand shares of Enzo Biochem Inc